Table 1

Common adverse effects of antibiotics used to treat NTM infections in patients with CF#

Antibiotic (delivery route)Common adverse effectsSuggested monitoring
Amikacin (intravenous; intramuscular)Nephrotoxicity
Auditory-vestibular toxicity (tinnitus, high-frequency hearing loss)
Trough levels
Serum creatinine
Amikacin (nebulisation)None described
Azithromycin (oral)+Nausea, vomiting, diarrhoea
Auditory-vestibular toxicity
Prolonged QTc
Symptoms
Audiology
ECG
Bedaquiline (oral)Headaches, dizziness, joint aches
Prolonged QTc
Liver enzyme derangement
Symptoms
ECG
LFT
Cefoxitin (intravenous)Fever, rash
Eosinophilia, anaemia, leukopenia, thrombocytopenia
Interference with serum creatinine measurement
Symptoms
FBC
Clofazimine (oral)Discoloration of skin or sclera
Enteropathy (can mimic pancreatic insufficiency), nausea and vomiting
Symptoms
Ethambutol (oral)+Optic neuritisSymptoms, colour vision and acuity
Imipenem (intravenous)Nausea, vomiting, diarrhoea
Hepatitis
Symptoms
LFT
Linezolid (oral)Anaemia, leukopenia, thrombocytopenia
Peripheral neuropathy, optic neuritis
FBC
Symptoms/clinical
Minocycline (oral)Photosensitivity, skin discolouration
Nausea, vomiting, diarrhoea
Vertigo
Symptoms
Moxifloxacin (oral)Nausea, vomiting, diarrhoea
Insomnia, agitation, anxiety
Tendonitis
Photosensitivity
Prolonged QTc
Symptoms
ECG
Rifabutin (oral)+Leukopenia, anterior uveitis (when combined with clarithromycin), flu-like symptoms (polyarthralgia or myalgia)Symptoms
FBC
Rifampicin (oral)+Orange discolouration of bodily fluids, fever, chills, nausea, vomiting, diarrhoea
Hepatitis
Thrombocytopenia
Renal failure
Increased drug metabolism
Symptoms
LFT
FBC
EUC
Streptomycin (intravenous, intramuscular)NephrotoxicityTrough levels, serum creatinine
Tigecycline (intravenous)Nausea, vomiting, diarrhoea
Pancreatitis
Hypoproteinaemia, bilirubinaemia
Symptoms
Serum amylase, lipase
LFT plus albumin

LFT: liver function test; FBC: full blood count; EUC: electrolytes, urea and creatinine; QTc: corrected QT interval. #: based on United States CF Foundation (USCF) and European CF society (ECFS) consensus recommendations [46]; : primarily used for Mycobacterium abscessus complex; +: primarily used for MAC. Reproduced from [10] with permission.